MYRIAD GENETICS, INC. Deferred Tax Assets, Capital Loss Carryforwards
MYRIAD GENETICS, INC. (MYGN) had Deferred Tax Assets, Capital Loss Carryforwards of $0 as of 2014-06-30, per its 10-K filed 2014-08-13.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2014-08-13
- 2014-06-30: Deferred Tax Assets, Capital Loss Carryforwards $0.00.
- 2013-06-30: Deferred Tax Assets, Capital Loss Carryforwards $1.42M.
- 2012-06-30: Deferred Tax Assets, Capital Loss Carryforwards $1.55M.
- 2011-06-30: Deferred Tax Assets, Capital Loss Carryforwards $1.75M.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards |
|---|---|
| 2014-06-30 | $0.00 10-K · filed 2014-08-13 |
| 2013-06-30 | $1.42M 10-K · filed 2014-08-13 |
| 2012-06-30 | $1.55M 10-K · filed 2013-08-14 |
| 2011-06-30 | $1.75M 10-K · filed 2012-08-15 |
| 2010-06-30 | $1.85M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |